Traumatic Optic Neuropathy Treatment Trial 2
NCT03308448
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
93
Enrollment
OTHER
Sponsor class
Conditions
Traumatic Optic Neuropathy
Interventions
DRUG:
Recombinant human erythropoietin
Sponsor
Iran University of Medical Sciences
Collaborators
[object Object]
[object Object]